BlossomHill Therapeutics Statistics
Total Valuation
BLSM has a market cap or net worth of $758.43 million. The enterprise value is $686.43 million.
| Market Cap | 758.43M |
| Enterprise Value | 686.43M |
Important Dates
The last earnings date was Friday, September 18, 2026, before market open.
| Earnings Date | Sep 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BLSM has 30.64 million shares outstanding.
| Current Share Class | 30.64M |
| Shares Outstanding | 30.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +5.18% |
| Owned by Insiders (%) | 8.18% |
| Owned by Institutions (%) | 5.78% |
| Float | 16.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 9.43 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.42, with a Debt / Equity ratio of 0.28.
| Current Ratio | 5.42 |
| Quick Ratio | 5.12 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -80.79% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.30M |
| Employee Count | 63 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 66.91 |
| Average Volume (20 Days) | 201,489 |
Short Selling Information
The latest short interest is 110,782, so 0.36% of the outstanding shares have been sold short.
| Short Interest | 110,782 |
| Short Previous Month | 111,892 |
| Short % of Shares Out | 0.36% |
| Short % of Float | 0.67% |
| Short Ratio (days to cover) | 0.18 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -85.24M |
| Pretax Income | -81.60M |
| Net Income | -81.60M |
| EBITDA | -84.72M |
| EBIT | -85.24M |
| Earnings Per Share (EPS) | -$31.83 |
Balance Sheet
The company has $95.38 million in cash and $23.37 million in debt, with a net cash position of $72.01 million or $2.35 per share.
| Cash & Cash Equivalents | 95.38M |
| Total Debt | 23.37M |
| Net Cash | 72.01M |
| Net Cash Per Share | $2.35 |
| Equity (Book Value) | 82.04M |
| Book Value Per Share | -63.15 |
| Working Capital | 82.35M |
Cash Flow
In the last 12 months, operating cash flow was -$56.89 million and capital expenditures -$678,000, giving a free cash flow of -$57.56 million.
| Operating Cash Flow | -56.89M |
| Capital Expenditures | -678,000 |
| Depreciation & Amortization | 521,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -57.56M |
| FCF Per Share | -$1.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BLSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -10.55% |
| FCF Yield | -7.44% |
Analyst Forecast
The average price target for BLSM is $35.40, which is 43.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.40 |
| Price Target Difference | 43.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |